MedTrace Logo

Electrical Skin Conductance Monitoring as an Assessment of Post Operative Pain Scores

NCT02408263 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-08-28

Study results available
· View outcomes & findings →

Summary

Pain has been defined as a subjective experience. Various pain assessment tools, (such as NRS) have been developed and validated to objectively monitor and treat pain. There are certain patient populations, in whom, the current pain assessment tools cannot be used effectively due to communication problems such as cognitively impaired patients. In the US, the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) has made it mandatory to monitor and treat pain. In the absence of reliable pain assessment tools that would objectively measure pain, there is also risk of under treatment and overtreatment of pain that may lead to negative outcomes. Therefore, a monitor that is able to predict pain levels objectively, will help to achieve above goals. The investigators are using Skin Conductance Algesimeter (SCA) to measure pain by analyzing changes in skin conductance.

Conditions

  • Postoperative Pain

Interventions

PROCEDURE

Total Hip Replacement (THR) and Total Knee Replacement (TKR)

Total Hip Replacement is a surgical procedure where the cartilage and bone of the hip joint is replaced with artificial materials. Total Knee Replacement involves replacement of all three compartments of the knee the medial, the lateral and patellofemoral compartment.

Sponsors & Collaborators

  • Oslo University Hospital

    collaborator OTHER

  • Weill Medical College of Cornell University

    collaborator OTHER

  • Hospital for Special Surgery, New York

    lead OTHER

Principal Investigators

  • Semih Gungor, MD · Hospital for Special Surgery, New York

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-07-31
Completion
2011-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02408263 on ClinicalTrials.gov